Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Pushing for Behavioral Health Data Exchange

Although certain providers are not eligible for Meaningful Use incentives, stakeholders are working to incorporate their data for a more accurate patient picture.

Thumbnail

Making Mobile Health Personal

Mobile apps have evolved to highly personal tools helping tailor treatment and prevention for numerous conditions.

Thumbnail

Assns.' report aims to foster better shared decision-making

What patients do and don't do should be considered in programs designed to improve care and patient outcomes, according to a report from the American College of Cardiology, American Heart Association, American Association of Cardiovascular and Pulmonary Rehabilitation, American Academy of Family Physicians and the American Nurses Association in collaboration with other professional organizations.

Thumbnail

2014 National Health IT Week Has Huge Impact

The recognition week continues to grow with greater awareness among stakeholders, including legislators, of health IT challenges.

Thumbnail

Get to Know Hearst Health & Its Innovation Lab

The venerable company has launched an impressive effort in the healthcare field.

Thumbnail

Technology, Teamwork, Transitions: Highlights from the 2014 Healthcare Leadership Forum

The fourth annual forum brought together an insightful group of speakers addressing care in and outside of the care delivery system.

LightAide innovator wins Boston Children's Hospital's Rising Star award

Boston Children's Hospital named Catherine Rose, PhD, MBA, from Philips Healthcare as the recipient of its Rising Star Award.

Thumbnail

2015 payment final rule addresses chronic care, EHRs

A final rule on 2015 Medicare physician payments addresses chronic care management (CCM) and requirements for the EHRs supporting the services.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.